ERS Genomics Limited has announced that the Japanese Patent Office (JPO) has rejected arguments filed in opposition to the second Japanese patent. In addition, the JPO has allowed a third CVC patent which covers a chimeric version of the Cas9 protein.

Lonza has launched the next generation of its Nucleofector® Platform.

AMSBIO has announced a new range of AAV reference materials of full capsids and empty capsids of 6 different serotypes.

Genomic sequencing service provider Macrogen Europe has achieved a significant upgrade to its next-generation sequencing capacity.

Sphere Fluidics has announced it has enhanced the capability and performance of its Cyto-Mine® System. The simplified design offers improved functionality to help streamline workflows, reduce costs, increase throughput, and enable high-value clones to be captured in a single run.

Bio-Rad Laboratories, Inc. has announced the launch of the SEQuoia RiboDepletion Kit, which improves assay efficiency by eliminating irrelevant ribosomal RNA (rRNA) fragments from an RNA-Seq library.

ERS Genomics Limited and GenScript Biotech Corporation have announced a non-exclusive license agreement granting GenScript access to ERS Genomics’ CRISPR/Cas9 patent portfolio.

Isohelix and AutoGen, Inc. have signed a far-reaching supply agreement. This follows the successful validation of the Isohelix GeneFix™ range of saliva collection products on the AutoGen FlexSTAR and FlexSTAR+ DNA extraction workflows.

Bio-Rad Laboratories has announced the launch of the SARS-CoV-2 Variant RT-PCR Assays for research use only. The assays can detect SARS-CoV-2 variants of concern.

Northern Ireland Science Festival, in conjunction with Linen Biennale and funded by Northern Ireland Arts and Business, recently rolled out the virtual red carpet to premier Fusion Antibodies Head of Scientific Affairs, Dr Anthony O’Kane’s ‘Translating Linen.’